Older adults prescribed gabapentinoids may not experience increased long-term fracture risk during treatment, according to results published in The Lancet Healthy Longevity. Man, PhD, CStat, FHEA, FRSM, FRSPH, the senior author of the study and a pharmacoepidemiologist and medical statistician at University College London, told Healio.
Older adults prescribed gabapentinoids may not experience increased long-term fracture risk during treatment, according to results published in The Lancet Healthy Longevity.
Man, PhD, CStat, FHEA, FRSM, FRSPH, the senior author of the study and a pharmacoepidemiologist and medical statistician at University College London, told Healio.
"Even when [patients] started the treatment on gabapentinoids, it had a 30% higher [fracture] risk compared with nontreatment periods.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Older adults prescribed gabapentinoids may not experience increased long-term fracture risk during treatment, according to results published in The Lancet Healthy Longevity. Man, PhD, CStat, FHEA, FRSM, FRSPH, the senior author of the study and a pharmacoepidemiologist and medical statistician at University College London, told Healio. "Even when [patients] started the treatment on gabapentinoids, it had a 30% higher [fracture] risk compared with nontreatment periods.
Open the app view to save this story, compare related coverage, and continue from the same source.